University of Adelaide Library

Adelaide Research and Scholarship : Schools and Disciplines : School of Medicine : Surgery : Surgery publications

Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/74563

Type: Journal article
Title: Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery
Author: Jervis-Bardy, J.
Wormald, P.J.
Citation: International Forum of Allergy & Rhinology, 2012; 2(2):111-115
Publisher: American Rhinologic Society
Issue Date: 2012
ISSN: 2042-6976
2042-6984
Statement of
Responsibility: 
Joshua Jervis-Bardy, Peter-John Wormald
Abstract: BACKGROUND: Persistent infection following endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) is a frustrating entity for the patient and rhinologist alike. Mupirocin nasal washes have been proposed as an efficacious treatment in such patients. Two small studies have reported excellent short-term posttreatment outcomes; however, the long-term microbiological outcomes following treatment are not known; likewise, the rate of mupirocin-resistance following treatment has not been explored. METHODS: This was a retrospective chart review of 61 patients with Staphylococcus aureus (S. aureus)-positive surgically-recalcitrant CRS having undergone 0.05% mupirocin nasal rinse treatment, twice daily for 4 weeks. Specific outcomes reported included posttreatment culture results, time to first posttreatment S. aureus culture, and mupirocin-sensitivity following treatment. RESULTS: Of 57 patients meeting minimal posttreatment follow-up criteria, 42 (73.7%) progressed to microbiological failure by subsequently cultured S. aureus. Mean time to first positive culture was 144 days. Of the 42 patients who progressed to microbiological relapse, full antibiotic sensitivity data was available for 41; of these, only 1 was found to subsequently harbor a mupirocin-resistant strain of S. aureus, thus yielding a posttreatment resistance rate of 2.4%. CONCLUSION: Treatment with mupirocin nasal washes in S. aureus-positive, surgically recalcitrant CRS has a high microbiological failure rate, with 73.7% of patients subsequently re-culturing S. aureus. Our current treatment regime of 0.05% nasal washes twice daily for 4 weeks is associated with a posttreatment resistance rate that is consistent with other studies of topical mupirocin use, suggesting that mupirocin washes are no more likely to induce resistance than nasal vestibule decolonization in the high-risk medical or surgical patient.
Keywords: mupirocin; antibiotic-resistance; staphylococcus aureus; chronic rhinosinusitis; post-treatment outcome
Rights: © 2012 ARS-AAOA, LLC.
RMID: 0020122355
DOI: 10.1002/alr.20106
Appears in Collections:Surgery publications
View citing articles in: Web of Science
Google Scholar
Scopus

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

© 2008 The University of Adelaide
library@adelaide.edu.au
CRICOS Provider Number 00123M
Service Charter | Copyright | Privacy | Disclaimer